Biohaven Pharmaceutical (BHVN) Company Long-Term Loans and Borrowings

Symbol and logo of brand Biohaven Pharmaceutical (BHVN)

Biohaven Ltd. (BHVN) specializes in developing treatments for neurodegenerative pathologies and migraines, leveraging patient commitment. However, R&D expenses coupled with a revenue deficit are leading to the depletion of reserves and a search for borrowed funds, as captured by the metric at 0.28. Simultaneously, the company is implementing eco-standards and bioethics. This chart of stock quotes clearly illustrates the issuer's current financial dynamics.

BHVN biohavenpharma.com: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for Biohaven Pharmaceutical (BHVN)

- price and consensus price forecast:
Stock Price biohavenpharma.com|BHVN - Price Target Chart
- market capitalization data:
Market Value Biohaven|BHVN - Total Company Value
- book capitalization data:
Net Asset Value per Share Biohaven|BHVN - Book Capitalization|Market Value to Book Value Ratio biohavenpharma.com|BHVN - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Biohaven Ltd.|BHVN - Long-Term Debt to Equity|Current Liabilities to Capital Biohaven Corp|BHVN - Company Aggregate Debts|Debt to Net Assets Ratio Biohaven|BHVN - Company Long-Term Debts|Company Short-Term Debts Biohaven
Comprehensive company analysis:BHVN (biohavenpharma.com)
Manufactured products of Biohaven

Long-term debt records the total volume of credit obligations with maturities exceeding one year, allowing for an assessment of financial stability and the cost of strategic capital. By analyzing the current level of the business's long-term borrowed capital, an investor can evaluate the risks of Biohaven Ltd. (BHVN), whose massive expenditures on the final stages of clinical trials require significant external financing until the drugs are commercialized.

Who Biohaven Ltd. competes with

biogen.com - Company Long-Term Debts|Company Long-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Long-Term Loans and Borrowings|Company Long-Term Debt AXSM|ACADIA Corp (ACAD) - Long-Term Debt|Company Long-Term Debts Xenon Pharmaceuticals|Company Long-Term Debt vikingtherapeutics.com|SUPN (Supernus) - Company Long-Term Debts|Long-Term Debt Volume CPRX (Catalyst Pharma)|DNLI: Company Long-Term Debt|Long-Term Debt Harmony Corp HRMY|Company Long-Term Debts Amylyx Pharmaceuticals (AMLX)|TRVI - Company Long-Term Loans and Borrowings|PRAX: Company Long-Term Debts|Company Long-Term Debts Anavex|Company Long-Term Liabilities CeriBell Corp|Company Long-Term Debt prothena.com|Alector, Inc. - Company Long-Term Debts|Long-Term Debt ANNX (annexonbio.com)|OMER - Company Long-Term Debt|NGNE - Company Long-Term Indebtedness|Company Long-Term Liabilities AC Immune Corp (ACIU)|VYGR: Company Long-Term Loans and Borrowings|Neumora Therapeutics (NMRA) - Company Long-Term Debt|Company Long-Term Debt scilexholding.com|Tevogen Bio (TVGN) - Company Long-Term Liabilities|Amount of Long-Term Liabilities Alpha Cognition Corp|Company Long-Term Debts Cognition Therapeutics CGTX|Company Long-Term Indebtedness Inhibikase Pharma IKT|Company Long-Term Liabilities SAVA|Long-Term Debt Volume Assertio Holdings ASRT|COYA - Company Long-Term Debts|VTGN - Company Long-Term Debt|Company Long-Term Debts ovidrx.com OVID|Company Long-Term Loans and Borrowings Acumen Pharmaceuticals, Inc|Company Long-Term Liabilities CervoMed Inc.|Company Long-Term Debt ATHE|Company Long-Term Debt Clene Inc. CLNN|Company Long-Term Indebtedness PEPG (pepgen.com)|JUNS - Company Long-Term Debt|Company Long-Term Indebtedness Relmada Corp RLMD|ANVS (Annovis Bio, Inc.) - Company Long-Term Debts|Grace Therapeutics, Inc. (GRCE) - Long-Term Debt|AIFF: Company Long-Term Liabilities|KLTO (Klotho Neurosciences) - Company Long-Term Debts|NRSN - Company Long-Term Debt|Company Long-Term Loans and Borrowings RVPH|MetaVia Inc - Company Long-Term Debt|Long-Term Debt neuraxis.com (NRXS)|Company Long-Term Debts Helius Medical Technologies HSDT|Company Long-Term Debt Passage Bio Inc. PASG|Company Long-Term Debts NEUP (Neuphoria)|NERV: Long-Term Debt Volume|Company Long-Term Debt ATHA|addextherapeutics.com (ADXN) - Long-Term Debt|ALZN - Company Long-Term Debts|Company Long-Term Loans and Borrowings Cyclerion|Company Long-Term Debts PTIX|Company Long-Term Debts pasitheaclinics.com KTTA|Company Long-Term Liabilities Cortigent CRGT|Company Long-Term Debt avenuetx.com ATXI|BCLI (BrainStorm Cell Therapeutics) - Company Long-Term Debts|CARA: Long-Term Debt|Company Long-Term Debt Chromocell Therapeutics Corporation|Company Long-Term Indebtedness Eliem Therapeutics Inc.|ITCI - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings LBPH|Company Long-Term Debt Marinus Pharmaceuticals, Inc. (MRNS)|Company Long-Term Debt NKGen Biotech Inc NKGN|Company Long-Term Liabilities NeuroBo (NRBO)|Amount of Long-Term Liabilities Sage Therapeutics Inc SAGE|Synaptogenix, Inc. (SNPX) - Company Long-Term Debts|trevena.com (TRVN) - Company Long-Term Indebtedness|vigilneuro.com - Company Long-Term Liabilities|Anew Medical Inc. (WENA) - Long-Term Debt Volume|Company Long-Term Debts Cerevel